Nearly one in 30 Americans over the age of 40 experience low vision significant visual impairment that can’t be corrected with glasses, contact lenses, medication or surgery.
Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens
GENEVA–(BUSINESS WIRE)–Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens
Topcon Launches the Maestro2 with Automated OCTA
CAPELLE AAN DEN IJSSEL, The Netherlands–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/OCTAngiography?src=hash" target="_blank">#OCTAngiography</a>–Topcon is pleased to announce the launch of the Maestro2 Automa…
Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens
GENEVA–(BUSINESS WIRE)–Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens
Mount Sinai West offers minimally invasive procedure to treat non-cancerous thyroid nodules
Mount Sinai West has begun offering a minimally invasive procedure to treat non-cancerous thyroid nodules that are symptomatic and would have otherwise required invasive surgery for removal.
Grassroots to glass ceilings: WIO addresses inequities in ophthalmology
COEUR D’ALENE, Idaho — There continues to be a “leaky pipeline” on the way to holding higher-level faculty positions for women MDs, according to Lynn K. Gordon, MD, PhD, who is senior associate dean for equity and diversity inclusion at the David Geffe…